$APHP
American Picture House Corp Stock $aphp

$aphp Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000149315224031503 Filed on August 13, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q2
Revenue			$0.00
YoY Change
Cost Of Revenue			$0.00
YoY Change
Gross Profit			$0.00
YoY Change
Gross Profit Margin
Selling, General & Admin	$315.6K	$391.4K	$395.1K
YoY Change	-36.28%	-0.93%
% of Gross Profit
Research & Development		$703.00
YoY Change
% of Gross Profit
Depreciation & Amortization	$5.840K	$5.830K
YoY Change	2236.0%
% of Gross Profit
Operating Expenses	$315.6K	$392.1K	$395.1K
YoY Change	-37.39%	-0.76%
Operating Profit	-$315.6K	-$392.1K	-$395.1K
YoY Change	-37.39%	-0.76%
Interest Expense	-$10.95K	-$12.44K	-$340.00
YoY Change	-465.85%	3558.82%
% of Operating Profit
Other Income/Expense, Net	-$10.94K	-$12.44K	-$342.00
YoY Change	312.51%	3536.26%
Pretax Income	-$326.5K	-$404.6K	-$395.5K
YoY Change	-35.56%	2.3%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$326.5K	-$404.6K	-$395.5K
YoY Change	-35.56%	2.3%	180.11%
Net Earnings / Revenue
Basic Earnings Per Share	$0.00	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	111.4M shares	111.4M shares	100.7M shares
Diluted Shares Outstanding	111.4M shares	111.3M shares	100.7M shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$0.00	$8.060K	$265.7K
YoY Change	-100.0%	-96.97%
Cash & Equivalents		$8.058K	$265.7K
Short-Term Investments
Other Short-Term Assets	$22.03K	$9.600K	$36.21K
YoY Change	-57.37%	-73.49%
Inventory
Prepaid Expenses	$22.03K	$9.601K
Receivables	$35.00K	$38.71K	$25.63K
Other Receivables	$0.00	$0.00	$1.230K
Total Short-Term Assets	$61.12K	$56.37K	$328.8K
YoY Change	-90.16%	-82.85%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles	$81.45K	$87.28K
YoY Change	830.82%
Long-Term Investments
YoY Change
Other Assets	$349.4K	$346.6K	$131.6K
YoY Change	94.66%	163.44%
Total Long-Term Assets	$827.1K	$830.0K	$131.6K
YoY Change	339.33%	530.97%
TOTAL ASSETS
Total Short-Term Assets	$61.12K	$56.37K	$328.8K
Total Long-Term Assets	$827.1K	$830.0K	$131.6K
Total Assets	$888.2K	$886.4K	$460.3K
YoY Change	9.7%	92.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$835.9K	$502.6K	$119.8K
YoY Change	491.36%	319.56%
Accrued Expenses	$18.18K	$17.44K	$13.84K
YoY Change		26.01%
Deferred Revenue
YoY Change
Short-Term Debt	$107.7K	$113.5K	$102.5K
YoY Change		10.66%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.012M	$683.5K	$236.1K
YoY Change	549.24%	189.44%
LONG-TERM LIABILITIES
Long-Term Debt	$149.9K	$149.9K	$149.9K
YoY Change	0.0%	0.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$149.9K	$149.9K	$149.9K
YoY Change	0.0%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.012M	$683.5K	$236.1K
Total Long-Term Liabilities	$149.9K	$149.9K	$149.9K
Total Liabilities	$1.162M	$833.4K	$386.0K
YoY Change	279.95%	115.88%
SHAREHOLDERS EQUITY
Retained Earnings	-$7.249M	-$6.922M
YoY Change	57.24%
Common Stock	$11.14K	$11.14K
YoY Change	-97.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$273.5K	$53.03K	$74.28K
YoY Change
Total Liabilities & Shareholders Equity	$888.2K	$886.4K	$460.3K
YoY Change	9.7%	92.56%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q2
OPERATING ACTIVITIES
Net Income	-$326.5K	-$404.6K	-$395.5K
YoY Change	-35.56%	2.3%	180.11%
Depreciation, Depletion And Amortization	$5.840K	$5.830K
YoY Change	2236.0%
Cash From Operating Activities	-$30.71K	-$305.8K	-$318.0K
YoY Change	-92.3%	-3.85%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$19.00K
YoY Change	-100.0%
Acquisitions
YoY Change
Other Investing Activities	-$2.880K	-$2.820K	-$10.20K
YoY Change	-89.31%	-72.35%
Cash From Investing Activities	-$2.880K	-$21.82K	-$10.20K
YoY Change	-91.99%	113.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	25.52K	310.6K	562.4K
YoY Change	-96.36%	-44.77%
NET CHANGE
Cash From Operating Activities	-30.71K	-305.8K	-318.0K
Cash From Investing Activities	-2.880K	-21.82K	-10.20K
Cash From Financing Activities	25.52K	310.6K	562.4K
Net Change In Cash	-8.070K	-17.06K	234.1K
YoY Change	-103.04%	-107.29%
FREE CASH FLOW
Cash From Operating Activities	-$30.71K	-$305.8K	-$318.0K
Capital Expenditures	$0.00	$19.00K
Free Cash Flow	-$30.71K	-$324.8K
YoY Change	-92.47%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6922254	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	53028	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	886409	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	209482	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent		usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent		usd
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue		usd
	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2024Q2	us-gaap	Gross Profit GrossProfit		usd
CY2023Q2	us-gaap	Gross Profit GrossProfit		usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense		usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense		usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	APHP	Reserve For Uncollectible Receivable ReserveForUncollectibleReceivable		usd
	APHP	Expiration Of Produced And Licensed Costs ExpirationOfProducedAndLicensedCosts		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets		usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables		usd
	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent		usd
	us-gaap	Increase Decrease In Notes Receivable Current IncreaseDecreaseInNotesReceivableCurrent		usd
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent		usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit		usd
	APHP	Conversion Of Accrued Expenses Into Options To Purchase Common Stock ConversionOfAccruedExpensesIntoOptionsToPurchaseCommonStock		usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets		usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent		usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8058	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	90377	usd
CY2024Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	50000	usd
CY2024Q2	APHP	Interest Payable On Loan InterestPayableOnLoan	10799	usd
CY2023Q4	APHP	Interest Payable On Loan InterestPayableOnLoan	11580	usd
CY2024Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	113448	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	683481	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	101957	usd
CY2024Q2	APHP	Economic Injury Disaster Loan Noncurrent EconomicInjuryDisasterLoanNoncurrent	149900	usd
CY2023Q4	APHP	Economic Injury Disaster Loan Noncurrent EconomicInjuryDisasterLoanNoncurrent	149900	usd
CY2024Q2	us-gaap	Liabilities Liabilities	833381	usd
CY2023Q4	us-gaap	Liabilities Liabilities	251857	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	111399325	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	111399325	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	109790991	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	109790991	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	11140	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	10979	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	3829	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	3829	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	3829	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	3829	shares
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6964142	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	5307810	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5021696	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	297093	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	548950	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	23003	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	169111	usd
	us-gaap	Cost Of Revenue CostOfRevenue	36701	usd
	us-gaap	Gross Profit GrossProfit	23003	usd
	us-gaap	Gross Profit GrossProfit	132410	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	380082	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	395120	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1882014	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	578723	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	703	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	703	usd
CY2024Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	11350	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	25325	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	392135	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	395120	usd
	us-gaap	Operating Expenses OperatingExpenses	1908042	usd
	us-gaap	Operating Expenses OperatingExpenses	578723	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-392135	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-395120	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1885039	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-446313	usd
CY2024Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	384	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	1712	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	486	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	2453	usd
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	12820	usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	2054	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	16005	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	3941	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-12436	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-342	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-15519	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1488	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-404571	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-395462	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1900558	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-447801	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-404571	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-395462	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1900558	usd
	us-gaap	Net Income Loss NetIncomeLoss	-447801	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	100754390	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	100754390	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-67756	usd
CY2023Q1	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	105000	usd
CY2023Q1	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	1160221	shares
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	105000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-52339	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-15095	usd
CY2023Q2	us-gaap	Share Price SharePrice	0.15
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	25000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	459834	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-395462	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	74277	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	297093	usd
CY2024Q1	us-gaap	Share Price SharePrice	0.20
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	15000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1258160	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1495987	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	74266	usd
CY2024Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.25
CY2024Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	229333	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	229333	usd
CY2024Q2	us-gaap	Share Price SharePrice	0.25
CY2024Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	154000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	154000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-404571	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	53028	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	53028	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1900558	usd
	us-gaap	Net Income Loss NetIncomeLoss	-447801	usd
	APHP	Reserve For Uncollectible Receivable ReserveForUncollectibleReceivable	193932	usd
	APHP	Expiration Of Produced And Licensed Costs ExpirationOfProducedAndLicensedCosts	15000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1258159	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	86000	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	25000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6583	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6765	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-150992	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-19584	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	3351	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	26440	usd
	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-1349	usd
	us-gaap	Increase Decrease In Notes Receivable Current IncreaseDecreaseInNotesReceivableCurrent	396200	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	119106	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-48914	usd
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-130000	usd
	APHP	Increase Decrease In Interest Payable Loan IncreaseDecreaseInInterestPayableLoan	-781	usd
	APHP	Increase Decrease In Interest Payable Loan IncreaseDecreaseInInterestPayableLoan	2787	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	50000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-35000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-741879	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-318032	usd
	APHP	Payments To Produced And Licensed Costs PaymentsToProducedAndLicensedCosts	7590	usd
	APHP	Payments To Produced And Licensed Costs PaymentsToProducedAndLicensedCosts	10195	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	22000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-29590	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10195	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	318408	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	178500	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	25300	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	75981	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	142500	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	29052	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	169000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	459834	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	575556	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	562353	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-195913	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	234126	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	203971	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	31573	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8058	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	265699	usd
	APHP	Conversion Of Accrued Expenses Into Options To Purchase Common Stock ConversionOfAccruedExpensesIntoOptionsToPurchaseCommonStock	105000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84B_eus-gaap--UseOfEstimates_zo3nzv5ZRLF7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to income taxes and contingencies. The Company bases its estimates on historical experience, known or expected trends, and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these financial statements. The results of these assumptions provide the basis for making estimates about the carrying amount of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q2	APHP	Cash Sipc Insured Amount CashSIPCInsuredAmount	500000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	38713	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	31948	usd
CY2023Q4	us-gaap	Allowance For Uncollectible Customers Liability For Acceptances AllowanceForUncollectibleCustomersLiabilityForAcceptances	193932	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2024Q2	us-gaap	Allowance For Uncollectible Customers Liability For Acceptances AllowanceForUncollectibleCustomersLiabilityForAcceptances	193932	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	9601	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	29185	usd
CY2024Q2	APHP	Filims In Development And Preproduction Stage FilimsInDevelopmentAndPreproductionStage	346556	usd
CY2023Q4	APHP	Filims In Development And Preproduction Stage FilimsInDevelopmentAndPreproductionStage	210633	usd
CY2024Q2	APHP	Produced And Licensed Content Costs ProducedAndLicensedContentCosts	346556	usd
CY2023Q4	APHP	Produced And Licensed Content Costs ProducedAndLicensedContentCosts	210633	usd
CY2024Q1	APHP	Impairment Assessment For Investment In Films And Licensed Program Rights Write Off ImpairmentAssessmentForInvestmentInFilmsAndLicensedProgramRightsWriteOff	15000	usd
CY2024Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5833	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6583	usd
CY2024Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	50000	usd
CY2024Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	50000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	387483471	shares
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	382900000	shares
CY2024Q2	APHP	Working Capital WorkingCapital	-627109	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6922254	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	94864	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	72864	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7583	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	87281	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	71864	usd
CY2024Q2	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
CY2023Q2	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
CY2024Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5833	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6583	usd
CY2021Q1	APHP	Economic Injury Disaster Loan Noncurrent EconomicInjuryDisasterLoanNoncurrent	149900	usd
CY2021Q1	us-gaap	Debt Instrument Term DebtInstrumentTerm	P30Y
CY2021Q1	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0375	pure
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q2	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	500000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	100000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	5083471	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.0125
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage	1	pure
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1258160	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	5000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	0	usd
CY2024Q2	us-gaap	Deferred Compensation Arrangement With Individual Recorded Liability DeferredCompensationArrangementWithIndividualRecordedLiability	5000	usd
CY2023Q4	us-gaap	Deferred Compensation Arrangement With Individual Recorded Liability DeferredCompensationArrangementWithIndividualRecordedLiability	20000	usd
CY2023Q1	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	105000	usd
CY2023Q1	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	1160221	shares
CY2023Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.125

Files In Submission

Name	View Source	Status
0001493152-24-031503-index-headers.html	Edgar Link	pending
0001493152-24-031503-index.html	Edgar Link	pending
0001493152-24-031503.txt	Edgar Link	pending
0001493152-24-031503-xbrl.zip	Edgar Link	pending
aphp-20240630.xsd	Edgar Link	pending
ex10-1.htm	Edgar Link	pending
ex10-10.htm	Edgar Link	pending
ex10-10_1.htm	Edgar Link	pending
ex10-11.htm	Edgar Link	pending
ex10-11_001.jpg	Edgar Link	pending
ex10-11_2.jpg	Edgar Link	pending
ex10-11_3.jpg	Edgar Link	pending
ex10-1_1.htm	Edgar Link	pending
ex10-1_2.htm	Edgar Link	pending
ex10-2.htm	Edgar Link	pending
ex10-2_001.jpg	Edgar Link	pending
ex10-2_002.jpg	Edgar Link	pending
ex10-2_003.jpg	Edgar Link	pending
ex10-3.htm	Edgar Link	pending
ex10-3_001.jpg	Edgar Link	pending
ex10-3_002.jpg	Edgar Link	pending
ex10-4.htm	Edgar Link	pending
ex10-5.htm	Edgar Link	pending
ex10-6.htm	Edgar Link	pending
ex10-6_1.htm	Edgar Link	pending
ex10-7.htm	Edgar Link	pending
ex10-8.htm	Edgar Link	pending
ex10-9.htm	Edgar Link	pending
ex10-9_1.htm	Edgar Link	pending
ex14-1.htm	Edgar Link	pending
ex14-2.htm	Edgar Link	pending
ex3-1.htm	Edgar Link	pending
ex3-2.htm	Edgar Link	pending
ex3-3.htm	Edgar Link	pending
ex3-3_001.jpg	Edgar Link	pending
ex3-3_002.jpg	Edgar Link	pending
ex3-4.htm	Edgar Link	pending
ex3-4_001.jpg	Edgar Link	pending
ex3-4_02.jpg	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
aphp-20240630_cal.xml	Edgar Link	unprocessable
aphp-20240630_pre.xml	Edgar Link	unprocessable
aphp-20240630_def.xml	Edgar Link	unprocessable
aphp-20240630_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$APHP
American Picture House Corp Stock $aphp

2024 Q3 Form 10-Q Financial Statement

#000149315224031503 Filed on August 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$APHP American Picture House Corp Stock $aphp

2024 Q3 Form 10-Q Financial Statement

#000149315224031503 Filed on August 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$APHP
American Picture House Corp Stock $aphp